论文部分内容阅读
胸部淋巴导管引流(简称“引流”)除具有免疫抑制作用外,还有排出非氧化的细胞分解产物、细菌和毒素,促进组织胺系统正常化和改善肝脏微循环的作用。据报道,支气管哮喘患者“引流”,至少对支气管哮喘过敏过程的免疫学和病理化学两个环节有作用。同时,“引流”不存在传统免疫疗法的不良影响。报告以“引流”疗法为主,治疗支气管哮喘16例。其中,重型12例,中等型4例;男4例,女12例;年龄为26～69岁,40岁以上13例。多数患者的病程为10年以内,一般疗法难以控制的哮喘状态。11例经常使用激素治疗,其中8例对激素产生了抗药性。部
Thoracic lymphatic drainage (referred to as “drainage”) in addition to immunosuppressive effects, but also discharge non-oxidative cell decomposition products, bacteria and toxins, to promote the normalization of histamine system and improve the role of the liver microcirculation. According to reports, “drainage” in patients with bronchial asthma, at least on the immune and pathological chemistry of allergic reactions in bronchial asthma have two parts. At the same time, “drainage” does not have the adverse effects of traditional immunotherapy. Report to “drainage” the main treatment of bronchial asthma in 16 cases. Among them, 12 were heavy and 4 were moderate; 4 were males and 12 were females; the age ranged from 26 to 69 years and 13 over the age of 40. The course of most patients is less than 10 years, the general treatment is difficult to control the asthma status. Of the 11 patients who regularly used hormonal therapy, 8 were hormonally resistant. unit